Multitarget ligands in antibacterial research: progress and opportunities. - Wikidata - awgldk - TriplyDB

Multitarget ligands in antibacterial research: progress and opportunities.

Multitarget ligands in antibacterial research: progress and opportunities.

http://www.wikidata.org/entity/Q38068475

about

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug Resistance-resistant antibiotics Small-molecule inhibitors of Staphylococcus aureus RnpA-mediated RNA turnover and tRNA processing Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting.Antiinfectives targeting enzymes and the proton motive force.Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.The biology of Mur ligases as an antibacterial target.Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerases inhibitors.Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.Is the GAIN Act a turning point in new antibiotic discovery?Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine.Essential Two-Component Systems Regulating Cell Envelope Functions: Opportunities for Novel Antibiotic Therapies.

P2860

Q26747572-C94779E7-4C5F-46C3-9BDE-F82FE27E0C36 Q28650583-5DE2C32D-E308-4760-B517-0EA200E57153 Q35169035-21234AB2-6B91-499E-A6B2-CF1BDFCB0E11 Q35178875-8927A5E6-B2C5-4489-B4C7-96849BC0B7E3 Q36419761-EAEA17D0-1747-4ABC-A61C-3798B654E6B1 Q37335706-879C70ED-9F0E-44CB-929F-B02C18431251 Q38240597-131237D2-4934-4DF3-A7C4-614C0CD3671B Q38897223-AF1CC28A-4D5D-466D-8EB9-50A42D5EC18B Q38949284-8E96A498-34A8-4595-839D-FD52644D27CD Q42268705-97435A59-F6B2-4774-963F-9163D6E7B7F4 Q47162787-90ED31E4-378F-46B0-94D0-17874C7D7527 Q48371459-494D2CC6-0DE4-47C7-8D4F-8CB37DBF0E83

P2860

Multitarget ligands in antibacterial research: progress and opportunities.

http://www.wikidata.org/entity/Q38068475

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Multitarget ligands in antibacterial research: progress and opportunities.

@en

type

label

Multitarget ligands in antibacterial research: progress and opportunities.

@en

prefLabel

Multitarget ligands in antibacterial research: progress and opportunities.

@en

P1433

Q38068475-8FC7C0A6-5841-4EE2-9A93-C91164404DFA

P1476

Q38068475-3DBCD727-CC0F-4DE9-8986-181C398AE0CD

P2093

Q38068475-2DCE01F2-3182-4760-A198-29BD5C312185

Q38068475-88E157E5-013F-4BAD-8B67-EF4A34B2E88C

P2860

Q38068475-00700F61-BEB2-4CAB-AAD5-C4448C972543

Q38068475-0092FF43-D48F-409F-9931-EF5B2859421E

Q38068475-03DAF50F-CC34-4D76-98F1-34F28FA80147

Q38068475-048A2103-C830-44F5-AF4A-EC1DB3AE2816

Q38068475-148DE9B0-B11A-420E-B88C-F5A9128440C5

Q38068475-19D79A1C-456E-4D93-AB87-8DA897E7E742

Q38068475-1DBAFAC2-DB92-4517-9397-D17E1FE6ADEC

Q38068475-2024BD46-39F8-43DE-A461-4E065344F3E6

Q38068475-289C66A6-C9CA-407F-9C45-AD4499DD3400

Q38068475-323ABD1E-352F-4880-A481-C20F2E26100D

P304

Q38068475-37F61C65-9FD4-4E49-8140-803538F70E42

P31

Q38068475-6BE994F3-0753-4D5A-ABFA-D577EFC24C05

P356

Q38068475-FE28F110-103E-43D8-9FEF-4553D502DB54

P407

Q38068475-8E90E952-573C-4A03-BAC5-97C8CFFAEC8B

P433

Q38068475-7393F21D-9E9E-4A0E-A738-9BFDAB7636E6

P478

Q38068475-3F134931-4117-411B-B952-DD64DAEA3B2E

P577

Q38068475-52DF6F88-1F1B-440B-829E-B60F32064541

P698

Q38068475-D38FD644-94C2-49DA-92E7-9247C3434510

P356

17460441.2013.743991

P1433

Expert Opinion on Drug Discovery

P1476

Multitarget ligands in antibacterial research: progress and opportunities.

@en

P2093

Lynn L Silver

http://www.w3.org/2001/XMLSchema#string

Stephen P East

http://www.w3.org/2001/XMLSchema#string

P2860

Carbapenems: past, present, and future

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

Combination therapies for combating antimicrobial resistance

Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase

Type IIA topoisomerase inhibition by a new class of antibacterial agents

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

Structure-guided design of cell wall biosynthesis inhibitors that overcome β-lactam resistance in Staphylococcus aureus (MRSA)

Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV

Structure Guided Development of Potent Reversibly Binding Penicillin Binding Protein Inhibitors

Antimicrobial activity of flavonoids

P304

143-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2013.743991

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23252414

http://www.w3.org/2001/XMLSchema#string